Study of Transcranial Magnetic Stimulation to Treat Adults Aged 18 to 80 After Endovascular Treatment for Acute Ischemic Stroke

What this Trial Is About

Researchers are evaluating the use of continuous theta burst stimulation cTBS, a form of transcranial magnetic stimulation, in patients who have acute ischemic stroke after undergoing endovascular treatment. This randomized, double-blind, sham-controlled trial aims to determine the safety and effectiveness of cTBS in improving outcomes after stroke caused by blockage in specific brain arteries. Participants are randomly assigned to one of two groups one group receives active cTBS along with usual medical care following endovascular treatment, while the other group receives sham placebo cTBS plus usual medical care. The study focuses on patients with acute anterior circulation ischemic stroke who meet specific imaging and clinical criteria, with treatment applied shortly after endovascular therapy. During the study, researchers will monitor changes in stroke-related brain damage volume, death rates, and neurological function within 5 days after enrollment. Secondary assessments include neurological deterioration, hemorrhage incidence, stroke recurrence, and functional recovery scores up to 90 days. Participants will undergo brain imaging, neurological evaluations, and clinical assessments throughout the study to track safety and treatment effects.

Effects of Transcranial Magnetic Stimulation After Endovascular Treatment for Acute Ischemic Stroke